Corvus Pharmaceuticals Inc buy HC Wainwright
Start price
20.01.26
/
50%
€13.70
Target price
20.01.27
-
Performance (%)
-16.86%
Price
31.07.26
€11.12
Summary
This prediction is currently active. The prediction for Corvus Pharmaceuticals Inc disappoints with a performance of -16.86%. This prediction currently runs until 20.01.27. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Corvus Pharmaceuticals Inc | -4.387% | -4.387% |
| iShares Core DAX® | 2,59 % | 2,69 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % |
| iShares S&P 500 | -0,37 % | -0,83 % |
Comments by HC_Wainwright for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals (NASDAQ:CRVS) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Ratings data for CRVS provided by MarketBeat
Stopped prediction by HC_Wainwright for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€3.00
26.03.25
26.03.25
€10.19
26.03.26
26.03.26
302.67%
27.03.26
27.03.26
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.03
14.01.25
14.01.25
€10.73
14.01.26
14.01.26
15.11%
15.01.26
15.01.26
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.15
02.01.25
02.01.25
€10.66
02.01.26
02.01.26
30.10%
03.01.26
03.01.26